DGRW
DividendWisdomTree U.S. Quality Dividend Growth Fund
WisdomTree · Tracks WisdomTree U.S. Quality Dividend Growth Index · Inception May 22, 2013
Composite score
Based on a 0.28% expense ratio.
Based on $16.60B in net assets.
Top-10 holdings represent 37.7% of net assets.
Dividend base · ETF wrapper · 1.26% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use DGRW in our tools
Tool · Cost
Compare DGRW's fee against another fund
Compounds the 0.28% expense ratio against a peer over decades.
Tool · Overlap
Compare DGRW's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Dividend funds.
Tool · TLH
Find a tax-loss harvesting partner for DGRW
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | NVIDIA Corp. | 7.50% |
| 2 | Apple Inc. | 5.46% |
| 3 | Microsoft Corp. | 4.75% |
| 4 | Exxon Mobil Corp. | 3.50% |
| 5 | Meta Platforms Inc | 3.26% |
| 6 | Coca-Cola Co (The) | 2.95% |
| 7 | Home Depot Inc. | 2.83% |
| 8 | Oracle Corp. | 2.54% |
| 9 | Alphabet Inc. | 2.46% |
| 10 | Alphabet Inc. | 2.44% |
Compare DGRW with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open DGRW at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.